1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is a lipid of Glycerophospholipids (GP) class. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine is associated with abnormalities such as Painful Bladder Syndrome, Dehydration, Renal tubular disorder, Gigantism and Tumor-Associated Vasculature. The involved functions are known as conjugation, Ligand Binding, Process, Laser-generated electromagnetic radiation and Blood Circulation. 1,2-distearoyl-sn-glycero-3-phosphoethanolamine often locates in Tissue membrane, Early endosome, Body tissue, Cell surface and Membrane. The associated genes with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine are R peptide, P4HTM gene, NHS gene, TSPO gene and SLC33A1 gene. The related lipids are Liposomes, 1,2-distearoylphosphatidylethanolamine, Micelles, Fatty Acids and sialogangliosides.

Cross Reference

Introduction

To understand associated biological information of 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

1,2-Distearoyl-sn-glycero-3-phosphoethanolamine is suspected in Renal tubular disorder, Entrapment, Painful Bladder Syndrome, Dehydration, Gigantism, Tumor-Associated Vasculature and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

MeSH term MeSH ID Detail
Adenocarcinoma D000230 166 associated lipids
Lung Neoplasms D008175 171 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Body Weight D001835 333 associated lipids
Prostatic Neoplasms D011471 126 associated lipids
Melanoma D008545 69 associated lipids
Carcinoma, Ductal, Breast D018270 19 associated lipids
Hepatoblastoma D018197 10 associated lipids
Mammary Neoplasms, Animal D015674 27 associated lipids
Lymphoma, B-Cell D016393 24 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with 1,2-Distearoyl-sn-glycero-3-phosphoethanolamine

Download all related citations
Per page 10 20 50 100 | Total 255
Authors Title Published Journal PubMed Link
Zorzi GK et al. Box Behnken design of siRNA-loaded liposomes for the treatment of a murine model of ocular keratitis caused by Acanthamoeba. 2019 Colloids Surf B Biointerfaces pmid:30384269
Williams JB et al. Codelivery of Doxorubicin and Verapamil for Treating Multidrug Resistant Cancer Cells. 2018 Pharm Nanotechnol pmid:30207210
Pawar VA et al. Drug-fortified liposomes as carriers for sustained release of NSAIDs: The concept and its validation in the animal model for the treatment of arthritis. 2018 Eur J Pharm Sci pmid:30219410
Li H et al. Folate-targeting annonaceous acetogenins nanosuspensions: significantly enhanced antitumor efficacy in HeLa tumor-bearing mice. 2018 Drug Deliv pmid:29608108
Sun Y et al. Hepatocellular carcinoma-targeted effect of configurations and groups of glycyrrhetinic acid by evaluation of its derivative-modified liposomes. 2018 Int J Nanomedicine pmid:29588589
You Y et al. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled Accumulation. 2018 Theranostics pmid:29556348
Zhang T et al. Polysialic acid-polyethylene glycol conjugate-modified liposomes as a targeted drug delivery system for epirubicin to enhance anticancer efficiency. 2018 Drug Deliv Transl Res pmid:29536348
Yuan S et al. Highly Sensitive Ratiometric Self-Assembled Micellar Nanoprobe for Nitroxyl and Its Application In Vivo. 2018 Anal. Chem. pmid:29332385
Chen L et al. Using PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugs. 2018 Nanoscale pmid:29308812
Qiao C et al. Intracellular accumulation and immunological responses of lipid modified magnetic iron nanoparticles in mouse antigen processing cells. 2017 Biomater Sci pmid:28516182